These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38700306)

  • 1. Dysbiosis in Irritable Bowel Syndrome.
    Abraham P; Pratap N
    J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
    Dale HF; Lied GA
    Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.
    Wielgosz-Grochowska JP; Domanski N; Drywień ME
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Wu Y; Li Y; Zheng Q; Li L
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
    Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
    J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    He Y; Xu R; Wang W; Zhang J; Hu X
    Medicine (Baltimore); 2020 Aug; 99(32):e21502. PubMed ID: 32769886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
    Herndon CC; Wang YP; Lu CL
    Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is irritable bowel syndrome an infectious disease?
    Thompson JR
    World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome and gut microbiota.
    Canakis A; Haroon M; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.